ABIONYX Pharma S.A.

ABNX.PA · PAR
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-€2-€2-€2-€1
Dep. & Amort.€0-€0€0€0
Deferred Tax€0€0€0€0
Stock-Based Comp.€0-€0€0€0
Change in WC€0€0-€0€1
Other Non-Cash€0€1€0-€1
Operating Cash Flow-€2-€2-€2-€1
Investing Activities
PP&E Inv.-€0€0-€0-€0
Net Acquisitions€0€0€0€0
Inv. Purchases€0€0€0€0
Inv. Sales/Matur.€0€0€0€0
Other Inv. Act.€0-€0€0-€0
Investing Cash Flow-€0-€0-€0-€0
Financing Activities
Debt Repay.-€0-€0-€0-€2
Stock Issued€0-€0€3€8
Stock Repurch.-€0-€3-€0€0
Dividends Paid€0€0€0€0
Other Fin. Act.€2€3€0-€3
Financing Cash Flow€2-€0€3€3
Forex Effect€0€0-€0-€0
Net Chg. in Cash€0-€2€1€2
Supplemental Information
Beg. Cash€3€5€4€2
End Cash€3€3€5€4
Free Cash Flow-€2-€2-€2-€1
ABIONYX Pharma S.A. (ABNX.PA) Financial Statements & Key Stats | AlphaPilot